Bleomycin Polidocanol Foam (BPF) Stability – In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations. (June 2020)
- Record Type:
- Journal Article
- Title:
- Bleomycin Polidocanol Foam (BPF) Stability – In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations. (June 2020)
- Main Title:
- Bleomycin Polidocanol Foam (BPF) Stability – In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations
- Authors:
- Sun, Yi
Gu, Hao
Yang, Xi
Cai, Ren
Shang, Ying
Hu, Li
Wang, Yungying
Chen, Hui
Lin, Xiaoxi - Abstract:
- Abstract : Objective: This study investigated the in vitro stability of a novel sclerosant, bleomycin polidocanol foam (BPF), for venous malformation (VM) sclerotherapy. Methods: The study was designed with control groups treated with polidocanol (0.5%, 1%, and 3%) only. The experimental groups included 21 BPFs, which was made by dissolving bleomycin at seven different concentrations (0.1%–1.5%) in polidocanol (0.5%, 1%, and 3%). The Tessari method was used to prepare sclerosant foam with a liquid:gas ratio of 1:4 at room temperature in vitro . The foam stability was measured for each group. The decay process, one component of foam stability, was recorded with a camera. Foam decay process experiments were performed 10 times per group. The stability indices included drainage rate, drainage time, half life, and microscopic measurement of the foams (mean bubble diameter, minimum and maximum bubble diameters, wall thickness, and bubble diameter distribution). Results: Compared with the control groups, the half lives of BPFs mainly increased significantly with the addition of bleomycin ( p < .001). BPF with 3% polidocanol and 0.1% bleomycin recorded the highest half life (246 ± 1.6 sec), and this group also achieved the smallest bubble diameter and wall thickness (69.9 μm and 5.80 μm) among the experimental groups. For the same polidocanol concentration, the bubble diameter and wall thickness increased when bleomycin was added. Conclusion: Bleomycin concentrations account forAbstract : Objective: This study investigated the in vitro stability of a novel sclerosant, bleomycin polidocanol foam (BPF), for venous malformation (VM) sclerotherapy. Methods: The study was designed with control groups treated with polidocanol (0.5%, 1%, and 3%) only. The experimental groups included 21 BPFs, which was made by dissolving bleomycin at seven different concentrations (0.1%–1.5%) in polidocanol (0.5%, 1%, and 3%). The Tessari method was used to prepare sclerosant foam with a liquid:gas ratio of 1:4 at room temperature in vitro . The foam stability was measured for each group. The decay process, one component of foam stability, was recorded with a camera. Foam decay process experiments were performed 10 times per group. The stability indices included drainage rate, drainage time, half life, and microscopic measurement of the foams (mean bubble diameter, minimum and maximum bubble diameters, wall thickness, and bubble diameter distribution). Results: Compared with the control groups, the half lives of BPFs mainly increased significantly with the addition of bleomycin ( p < .001). BPF with 3% polidocanol and 0.1% bleomycin recorded the highest half life (246 ± 1.6 sec), and this group also achieved the smallest bubble diameter and wall thickness (69.9 μm and 5.80 μm) among the experimental groups. For the same polidocanol concentration, the bubble diameter and wall thickness increased when bleomycin was added. Conclusion: Bleomycin concentrations account for different BPF stability. BPF stability mainly increased significantly with the addition of a small amount of bleomycin but this advantage was no longer apparent with increasing bleomycin dose. … (more)
- Is Part Of:
- European journal of vascular and endovascular surgery. Volume 59:Number 6(2020)
- Journal:
- European journal of vascular and endovascular surgery
- Issue:
- Volume 59:Number 6(2020)
- Issue Display:
- Volume 59, Issue 6 (2020)
- Year:
- 2020
- Volume:
- 59
- Issue:
- 6
- Issue Sort Value:
- 2020-0059-0006-0000
- Page Start:
- 1011
- Page End:
- 1018
- Publication Date:
- 2020-06
- Subjects:
- Bleomycin -- Foam -- Polidocanol -- Sclerotherapy -- Stability -- Venous malformation
Blood-vessels -- Endoscopic surgery -- Periodicals
Blood-vessels -- Surgery -- Periodicals
Vascular Surgical Procedures -- Periodicals
Vascular Surgical Procedures -- methods -- Periodicals
Vaisseaux sanguins -- Chirurgie -- Périodiques
Vaisseaux sanguins -- Chirurgie endoscopique -- Périodiques
Blood-vessels -- Endoscopic surgery
Blood-vessels -- Surgery
Endoscopy
Electronic journals
Periodicals
Electronic journals
617.413005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=1078-5884;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/ejvs/ ↗
http://www.harcourt-international.com/journals/ejvx/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/10785884 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/10785884 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejvs.2020.01.023 ↗
- Languages:
- English
- ISSNs:
- 1078-5884
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.747280
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 13454.xml